OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ALKM.TN57

Ste Chimique Alkimia SA

Commodity ChemicalsVerified

The company’s capital structure shows negative equity (-TND190.06M) and a debt-to-equity ratio of -0.37, indicating liabilities exceed assets. Liquidity is constrained, with cash and equivalents (TND6.58M) insufficient to cover short-term obligations, as reflected in a current ratio of 0.28. Free cash flow is negative (-TND36.11M), driven by operating cash outflows (-TND3.46M) and capital expenditures (-TND1.91M). Profitability metrics are weak: operating income is negative (-TND18.70M) and net income is -TND44.40M, with return on assets at -22.84%. Return on equity (23.36%) is elevated due to negative equity, not operational performance. These results fall below typical thresholds for Commodity Chemicals, where positive operating margins and asset returns are standard. Revenue is concentrated in sodium tripolyphosphate production and packaging, with geographic exposure in Tunisia and Algeria via joint ventures. No segment breakdown is disclosed, but the company’s reliance on a single plant in Ghannouch and a single product line increases operational risk. Growth appears stagnant, with reported revenue (TND168.51M) below analyst estimates (TND253.83M). Outlook data is absent, but historical performance suggests declining revenue and margins, consistent with industry headwinds in raw material pricing and regional demand. Risk factors include high leverage (TND70.26M long-term debt) and negative equity, with liquidity risk rated medium. Dilution risk is low, but the company’s negative free cash flow and operating losses may force future capital raises. Recent filings show no material events, but the 2026-04 sanctions on North African chemical exports could disrupt operations. No earnings call transcripts are available for further insight.

30-day price · ALKM.TN+1.20 (+9.4%)
Low$12.80High$14.00Close$14.00As of25 May, 00:00 UTC
Profile
CompanySte Chimique Alkimia SA
TickerALKM.TN
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Ste Chimique Alkimia SA produces and exports sodium tripolyphosphate for detergent manufacturing, operating in Tunisia and North Africa.

Classification. Classified in Commodity Chemicals under Basic Materials with 92% confidence, aligned with Chemicals sector.

The company’s capital structure shows negative equity (-TND190.06M) and a debt-to-equity ratio of -0.37, indicating liabilities exceed assets. Liquidity is constrained, with cash and equivalents (TND6.58M) insufficient to cover short-term obligations, as reflected in a current ratio of 0.28. Free cash flow is negative (-TND36.11M), driven by operating cash outflows (-TND3.46M) and capital expenditures (-TND1.91M). Profitability metrics are weak: operating income is negative (-TND18.70M) and net income is -TND44.40M, with return on assets at -22.84%. Return on equity (23.36%) is elevated due to negative equity, not operational performance. These results fall below typical thresholds for Commodity Chemicals, where positive operating margins and asset returns are standard. Revenue is concentrated in sodium tripolyphosphate production and packaging, with geographic exposure in Tunisia and Algeria via joint ventures. No segment breakdown is disclosed, but the company’s reliance on a single plant in Ghannouch and a single product line increases operational risk. Growth appears stagnant, with reported revenue (TND168.51M) below analyst estimates (TND253.83M). Outlook data is absent, but historical performance suggests declining revenue and margins, consistent with industry headwinds in raw material pricing and regional demand. Risk factors include high leverage (TND70.26M long-term debt) and negative equity, with liquidity risk rated medium. Dilution risk is low, but the company’s negative free cash flow and operating losses may force future capital raises. Recent filings show no material events, but the 2026-04 sanctions on North African chemical exports could disrupt operations. No earnings call transcripts are available for further insight.
Key takeaways
  • Negative equity and high leverage (-TND190.06M equity, TND70.26M debt) signal severe financial distress.
  • Operating losses (-TND44.40M net income) and weak liquidity (current ratio 0.28) highlight immediate cash flow risks.
  • Revenue underperformance (TND168.51M vs. TND253.83M estimate) suggests operational or market challenges.
  • Geographic and product concentration in Tunisia and sodium tripolyphosphate increases vulnerability to regional and commodity shocks.
  • --
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyTND
Revenue$168.5M
Gross profit$43.5M
Operating income-$18.7M
Net income-$44.4M
R&D
SG&A
D&A
SBC
Operating cash flow-$3.5M
CapEx-$1.9M
Free cash flow-$36.1M
Total assets$194.4M
Total liabilities$384.4M
Total equity-$190.1M
Cash & equivalents$6.6M
Long-term debt$70.3M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$190.1M
Net cash-$63.7M
Current ratio0.3
Debt/Equity-0.4
ROA-22.8%
ROE23.4%
Cash conversion8.0%
CapEx/Revenue-1.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricALKM.TNActivity
Op margin-11.1%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-26.3%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin25.8%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity-37.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual revenue253,830,000 TND
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 08:10 UTC#e4d62729
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 08:11 UTCJob: effc8dc5